Quarterly Result29 May 2026, 02:29 pm
Natco Pharma: Audited Financial Results for FY26
AI Summary
Natco Pharma Ltd has announced its audited financial results for the quarter and year ended March 31, 2026. The results, both standalone and consolidated, were prepared under Indian Accounting Standards (IND-AS) and Regulation 33 of the SEBI Listing Regulations. The Board of Directors approved the results along with amendments to the Corporate Social Responsibility Policy and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. The audit was conducted by BS Rand Co, Chartered Accountants, who issued an unmodified opinion.
Key Highlights
- Audited financial results (standalone and consolidated) for FY26 approved.
- Corporate Social Responsibility Policy and Code of Practices amended.
- Auditor's report with unmodified opinion enclosed.
- Meeting commenced at 11.45 a.m. and concluded at 14.05 p.m.
Price Impact
More from NATCOPHARM